Headache News and Research

Latest Headache News and Research

Review of COVID-19 clinical and viral characteristics, pathogenesis, and genetics

A new review article investigates the clinical and viral characteristics, pathogenesis, as well as human genetic basis associated with COVID-19.

27 Sep 2021

Vaccine hesitancy and vaccination passports – a Japanese study

A new study from Keio University, Japan, provides an evaluation of the effectiveness of relaxing public interactions following vaccination against COVID-19.

26 Sep 2021

Further evidence of safety and efficacy of mRNA-1273 vaccine in preventing symptomatic COVID-19 and SARS-CoV-2 infection

A recent study supports the efficacy of the mRNA-1273 vaccine in preventing COVID-19 illness and disease severity.

24 Sep 2021

Long-term effects of COVID-19 in children

A recent preprint deals with the incidence and importance of long COVID in children.

23 Sep 2021

People with neurologic conditions more likely to have had adverse childhood experiences

Adults with neurologic conditions are more likely than the general population to have had adverse childhood experiences such as abuse, neglect or household dysfunction, according to a study published in the September 22, 2021, online issue of Neurology Clinical Practice, an official journal of the American Academy of Neurology.

22 Sep 2021

Evidence for safety of Pfizer-BioNTech’s COVID-19 vaccine booster dose

Researchers have conducted a study demonstrating the safety of administering a third (booster) dose of Pfizer-BioNTech’s BNT162b2 vaccine.

22 Sep 2021

Could monitoring headaches after COVID-19 vaccination help identify rare cases of cerebral venous thrombosis?

Researchers from the Akershus University Hospital in Norway investigated 77 cases of CVT in vaccinated subjects to identify risks and warning signs to better predict these severe side effects.

21 Sep 2021

Neurokinin-1 receptor: a potential drug target for the treatment of COVID-19

An opinion article aims to provide evidence that SP could be the possible factor for initiating the cytokine storm during severe SARS-CoV-2 infection.

21 Sep 2021

New evidence confirms the efficacy of COVID-19 vaccination in cancer patients

The long-awaited confirmation of the efficacy of COVID-19 vaccination in patients with cancer has arrived, on time to be disseminated to a global audience at the annual congress of the European Society for Medical Oncology (ESMO Congress 2021), the leading professional society for medical oncology.

20 Sep 2021

I got a ‘mild’ breakthrough case. Here’s what I wish I’d known.

The test results that hot day in early August shouldn’t have surprised me — all the symptoms were there. A few days earlier, fatigue had enveloped me like a weighted blanket. I chalked it up to my weekend of travel. Next, a headache clamped down on the back of my skull.

20 Sep 2021

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine

Scientists have addressed the gap in the research regarding the adverse reactions to the COVID-19 vaccine among individuals with allergies.

20 Sep 2021

The influence of prior seasonal coronavirus infection on disease severity in COVID-19

A new study posted to the bioRxiv* server attempted to explore anti-spike IgG responses, Fc-gamma receptor (FcγR) activation, IgG targeting of immunodominant regions, and recall responses due to seasonal hCoV infections in non-hospitalized COVID-19 patients.

20 Sep 2021

mAb treatment can rapidly select for SARS-CoV-2 resistance, suggests study

A study evaluates the efficacy of a mAb to prevent disease progression in non-hospitalized persons with symptomatic SARS-CoV-2 infection.

17 Sep 2021

Review: Long COVID symptoms rarely persisted beyond 12 weeks in young people

Long COVID symptoms rarely persisted beyond 12 weeks in children and adolescents, unlike adults. But more studies were required to investigate the risk and impact of long COVID in young people to help guide vaccine policy decisions in Australia, according to a review led by the Murdoch Children's Research Institute (MCRI).

17 Sep 2021

Researchers examine the persistent effects of COVID-19 on vascular function of young adults

In a first-of-its-kind study, researchers have examined the persistent effects of SARS-CoV-2 infection on the vascular function of otherwise healthy young adults. The research, published in the American Journal of Physiology-Heart and Circulatory Physiology, was chosen as an APSselect article for September.

16 Sep 2021

Pediatric SARS-CoV-2 infections usually mild, says study

A new study in the journal BMC Pediatrics describes the clinical phenotypes and outcomes in a thousand children who developed COVID-19.

16 Sep 2021

When covid deaths are dismissed or stigmatized, grief is mixed with shame and anger

Months after Kyle Dixon died, his old house in Lanse, Pennsylvania, is full of reminders of a life cut short.

16 Sep 2021

IL-1-Ra autoantibodies observed in high frequency in children with PIMS/MIS-C

Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection typically affects children only mildly, multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS) is a serious but rare complication occurring after infection.

16 Sep 2021

School children in Switzerland show willingness to mask-wearing

A school-based survey has revealed that about 60% of students in Zurich perceive mask-wearing at school as a useful intervention for controlling SARS-CoV-2 transmission.

10 Sep 2021

German study finds lack of association between SARS-CoV-2 infection and neuroaxonal damage

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the virus that causes coronavirus disease 2019 (COVID-19) – is not associated with neuroaxonal damage, according to a new study from researchers in Germany.

8 Sep 2021

Headache News and Research

Latest Headache News and Research

Review of COVID-19 clinical and viral characteristics, pathogenesis, and genetics

Vaccine hesitancy and vaccination passports – a Japanese study

Further evidence of safety and efficacy of mRNA-1273 vaccine in preventing symptomatic COVID-19 and SARS-CoV-2 infection

Long-term effects of COVID-19 in children

People with neurologic conditions more likely to have had adverse childhood experiences

Evidence for safety of Pfizer-BioNTech’s COVID-19 vaccine booster dose

Could monitoring headaches after COVID-19 vaccination help identify rare cases of cerebral venous thrombosis?

Neurokinin-1 receptor: a potential drug target for the treatment of COVID-19

New evidence confirms the efficacy of COVID-19 vaccination in cancer patients

I got a ‘mild’ breakthrough case. Here’s what I wish I’d known.

Medical staff with a history of allergy suffered adverse reactions to BNT162b2 COVID-19 vaccine

The influence of prior seasonal coronavirus infection on disease severity in COVID-19

mAb treatment can rapidly select for SARS-CoV-2 resistance, suggests study

Review: Long COVID symptoms rarely persisted beyond 12 weeks in young people

Researchers examine the persistent effects of COVID-19 on vascular function of young adults

Pediatric SARS-CoV-2 infections usually mild, says study

When covid deaths are dismissed or stigmatized, grief is mixed with shame and anger

IL-1-Ra autoantibodies observed in high frequency in children with PIMS/MIS-C

School children in Switzerland show willingness to mask-wearing

German study finds lack of association between SARS-CoV-2 infection and neuroaxonal damage

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Headache News and Research

Latest Headache News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in